Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Metabolic and Fertility Improvement in Obese PCOS Women
NCT05702905Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in polycystic ovary syndrome (PCOS), sponsored by Peking University First Hospital. Started May 2023; status: recruiting.
02
Drugs
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05702905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05702905.